Results of Search
BCRJ: | 0251 | Cell Line: | XR63-IL3 | Tissue: | HEMATOPOIETIC | Organ: | | Cell Type: | MYELOID | Morphology: | LYMPHOBLAST | Pathology: | MYELOMA | Scientific Name: | MUS MUSCULUS | Vulgar Name: | MOUSE | Sex: | | Miscelaneous Info: | | Virus Succeptibility: | | Virus Resistance: | | Tumor Formation: | | Products: | Interleukin-3; IL-3 | Dependency Isoenzymes: | | Culture Medium: | RPMI-1640medium 90%, fetal bovine serum 10%. Subculture procedure: maintain
cultures from 1x105 to 1x106 cells/mL. | Consigner: | Dr. Fritz Melchers, Basel Institute for Immunology, Basel Switzeland. | Reference: | Eur J Immunol 18:97-104, 1988. | Additional Info: | XR63-IL3 was derived from X63AG-654 myeloma cell line. It was transformed py
pBV-1MTHA vector containing IL-3 cDNA cloned by Noma ( Nature, 1986,
319:640). Transformants produce mouse IL-3 in titres higher than those produced
by concanavalin A stimulating T cells. This IL-3 produced the 3H-Thymidine
uptake of T-cell line, a mast cell line and B leukemia cells, and enhanced the
productions of IgG1 by B-cells. Possible spontaneous revertants should be
eliminated by periodic culture of this cell line in the presence of 1mg/mL
Geneticin. May be distributed to scientific institutions; not to distributed for any
commercial use. | ATCC: | | Biosafety: | 01 |
|